Work

Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: a report from the Childhood Cancer Survivor Study (CCSS).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.10510

Authors: Kevin C. Oeffinger, Kayla Stratton, Melissa M. Hudson, Wendy Leisenring, Rebecca M. Howell, Suzanne L. Wolden, Louis S. Constine, Lisa Diller, Tara O. Henderson, Charles A. Sklar, Paul C. Nathan, Sharon M. Castellino, Dana Barnea, Susan A Smith, Gregory T. Armstrong, Leslie L. Robison

Institutions: Duke University, Fred Hutch Cancer Center, St. Jude Children's Research Hospital, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, University of Rochester Medicine, Harvard University, Dana-Farber Cancer Institute, University of Chicago, Hospital for Sick Children, Children's Healthcare of Atlanta

Language: English

Topic: Childhood Cancer Survivors' Quality of Life

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891236960

Cites:

Cited by: 1

Related to: 10